Active ingredient
Atezolizumab NDC Codes
Atezolizumab is an active ingredient in 3 finished products listed with the FDA, under 2 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Tecentriq, Tecentriq Hybreza
- Labelers
- Genentech, Inc.
- Strengths
- Atezolizumab 1875 mg/15mL; Hyaluronidase (Human recombinant) 30000 U/15mL; Atezolizumab 840 mg/14mL; Atezolizumab 1200 mg/20mL
- Dosage forms
- Injection, Solution, Injection
- Routes
- Intravenous, Subcutaneous
- Drug classes (FDA established)
- Programmed Death Receptor-1 Blocking Antibody, Endoglycosidase
- HCPCS / J-code
- J9022 — Injection, atezolizumab, 10 mg
- Package NDCs
- 5
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Tecentriq Hybrezaatezolizumab and hyaluronidase-tqjs | Atezolizumab 1875 mg/15mL; Hyaluronidase (Human recombinant) 30000 U/15mL | InjectionSubcutaneous | Genentech, Inc. | 50242-933 | 50242-0933-0150242-0933-86 | — |
| Tecentriqatezolizumab | Atezolizumab 840 mg/14mL | Injection, SolutionIntravenous | Genentech, Inc. | 50242-918 | 50242-0918-01 | J9022 |
| Tecentriqatezolizumab | Atezolizumab 1200 mg/20mL | Injection, SolutionIntravenous | Genentech, Inc. | 50242-917 | 50242-0917-0150242-0917-86 | J9022 |
Atezolizumab: common questions
- Which drugs contain Atezolizumab?
- Tecentriq, Tecentriq Hybreza.
- Is there a J-code for Atezolizumab?
- Med-Code's HCPCS directory matches J9022 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.